GlobeStar Therapeutics Corp (GSTC)
0.0008
0.00 (0.00%)
USD |
OTCM |
May 06, 15:48
GlobeStar Therapeutics 1 Year Total Returns (Daily): -81.63% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -81.63% |
May 02, 2024 | -82.98% |
May 01, 2024 | -86.00% |
April 30, 2024 | -85.45% |
April 29, 2024 | -83.64% |
April 26, 2024 | -84.35% |
April 25, 2024 | -83.64% |
April 24, 2024 | -84.07% |
April 23, 2024 | -84.62% |
April 22, 2024 | -84.62% |
April 19, 2024 | -87.88% |
April 18, 2024 | -88.24% |
April 17, 2024 | -86.72% |
April 16, 2024 | -88.97% |
April 15, 2024 | -89.71% |
April 12, 2024 | -88.73% |
April 11, 2024 | -87.22% |
April 10, 2024 | -89.33% |
April 09, 2024 | -88.19% |
April 08, 2024 | -90.28% |
April 05, 2024 | -87.84% |
April 04, 2024 | -90.64% |
April 03, 2024 | -90.14% |
April 02, 2024 | -85.51% |
April 01, 2024 | -85.51% |
Date | Value |
---|---|
March 28, 2024 | -86.57% |
March 27, 2024 | -79.22% |
March 26, 2024 | -68.84% |
March 25, 2024 | -62.91% |
March 22, 2024 | -66.67% |
March 21, 2024 | -68.84% |
March 20, 2024 | -67.74% |
March 19, 2024 | -72.30% |
March 18, 2024 | -71.62% |
March 15, 2024 | -78.92% |
March 14, 2024 | -76.74% |
March 13, 2024 | -74.36% |
March 12, 2024 | -78.05% |
March 11, 2024 | -78.05% |
March 08, 2024 | -78.66% |
March 07, 2024 | -79.20% |
March 06, 2024 | -78.95% |
March 05, 2024 | -73.65% |
March 04, 2024 | -74.85% |
March 01, 2024 | -77.01% |
February 29, 2024 | -78.89% |
February 28, 2024 | -80.00% |
February 27, 2024 | -85.00% |
February 26, 2024 | -83.72% |
February 23, 2024 | -84.09% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.62%
Minimum
May 27 2022
9.90K%
Maximum
May 21 2021
423.1%
Average
-45.95%
Median
Oct 31 2023
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.79% |
Palatin Technologies Inc | -3.65% |
iBio Inc | -90.87% |
Theriva Biologics Inc | -37.06% |
Oragenics Inc | -59.32% |